Advances in Immunotherapy for Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests th...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2017-01-01
|
| Col·lecció: | Journal of Immunology Research |
| Accés en línia: | http://dx.doi.org/10.1155/2017/3597613 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|